Discover

XOMA
XOMA Royalty Corporation
42.62
2 x 30.32
2 x 54.40
bid
ask
+
0.12
0.28%
2 @ 04:00 PM
42.62 +0.00 (0.00%)
Ytd60.29%
1y61.81%
42.24
day range
42.74
22.29
52 week range
42.81
Open42.50Prev Close42.50Low42.24High42.74Mkt Cap753.47M
Vol123.91KAvg Vol223.98KEPS1.57P/E27.15Forward P/E-56.64
Beta0.90Short Ratio3.33Inst. Own65.62%Dividend2.16Div Yield7.99
Ex Div Date01-03Earning05-1350-d Avg41.53200-d Avg33.481yr Est89.00
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-072024-09-0.44-0.390.0511.36%
2024-08-132024-06-0.26-0.28-0.02-7.69%
2024-05-092024-03-0.71-0.86-0.15-21.13%
2024-03-082023-12-0.36-0.49-0.13-36.11%
2023-11-072023-09-0.48-0.6-0.12-25.00%
2023-08-082023-06-0.52-0.59-0.07-13.46%
Upgrade / Downgrade
DateFirmActionFromTo
2024-12-13HC Wainwright & Co.UpgradeBuyBuy
2024-12-03HC Wainwright & Co.UpgradeBuyBuy
2024-12-02HC Wainwright & Co.UpgradeBuyBuy
2024-10-23HC Wainwright & Co.UpgradeBuyBuy
2024-09-20HC Wainwright & Co.UpgradeBuyBuy
2024-08-15HC Wainwright & Co.UpgradeBuyBuy
Profile
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Insider Holder
DateNameRelationQuantityDescription
2024-11-12BURNS THOMAS MChief Financial Officer20.11KSale
2023-01-05BVF PARTNERS L.P.Beneficial Owner of more than 10% of a Class of Security0.00Purchase
2024-05-14HERNDAY NATASHA ADirector3.04KStock Award(Grant)
2024-11-12HUGHES OWENChief Executive Officer34.98KSale
2024-05-14PERRY MATTHEW DDirector17.87KStock Award(Grant)
2023-10-02SITKO BRADLEY J.Chief Investment Officer7.10KPurchase
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29BVF Inc.3.63M96.73M30.84%
2024-09-29FMR, LLC1.10M29.35M9.36%
2024-09-29Blackrock Inc.535.66K14.26M4.55%
2024-09-29Vanguard Group Inc422.39K11.24M3.58%
2024-09-29Opaleye Management Inc.250.00K6.66M2.12%
2024-09-29Stonepine Capital Management, LLC195.10K5.19M1.66%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30Fidelity Capital Appreciation Fund296.00K7.88M2.51%
2024-10-30Fidelity Advisor Equity Growth Fund290.63K7.74M2.47%
2024-10-30Variable Insurance Products Fund-Growth Portfolio255.51K6.80M2.17%
2024-09-29Vanguard Total Stock Market Index Fund252.91K6.73M2.15%
2024-10-30iShares Russell 2000 ETF193.33K5.15M1.64%
2024-10-30Fidelity Growth Discovery Fund147.67K3.93M1.25%
Dividend
DividendDate
0.539062024-10-03
0.539062024-07-03
0.539062024-04-02
0.539062024-01-02
0.539062023-10-04
0.539062023-06-30
Split
SplitDate
1 : 202016-10-18
0.06667 : 12010-08-18